Evidence map›Paper›PMID 38485761›Full record

ArticleNature communications2024

Characterisation of colistin resistance in Gram-negative microbiota of pregnant women and neonates in Nigeria.

E A R Portal, K Sands, C Farley, I Boostrom, E Jones, M Barrell, M J Carvalho, R Milton, K Iregbu, F Modibbo and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Emergence of transmissibleApplied and environmental microbiology · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Frontiers in microbiology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Colistin Resistance Mediated byInfection and drug resistance · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

E A R Portal *Department of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK. edward.portal@biology.ox.ac.uk.ORCID 0000-0003-2142-3443
K Sands *Department of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK. kirsty.sands@biology.ox.ac.uk.ORCID 0000-0001-5049-4481
C FarleyDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
I BoostromDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
E JonesDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
M BarrellDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
M J CarvalhoDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
R MiltonDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
K IregbuNational Hospital Abuja, Abuja, Nigeria.ORCID 0000-0003-4780-0497
F ModibboMurtala Muhammad Specialist Hospital, Kano, Nigeria.
S UwaezuokeFederal Medical Centre -Jabi, Abuja, Nigeria.
C AkpuluIneos Oxford Institute for Antimicrobial Research, Department of Biology, University of Oxford, Oxford, UK.
L AuduNational Hospital Abuja, Abuja, Nigeria.ORCID 0000-0002-9836-2717
C EdwinDepartment of Medical Microbiology Aminu Kano Teaching Hospital, Kano, Nigeria.
A H YusufDepartment of Medical Microbiology Aminu Kano Teaching Hospital, Kano, Nigeria.ORCID 0000-0002-7782-3967
A AdeleyeDepartment of Medical Microbiology Aminu Kano Teaching Hospital, Kano, Nigeria.
A S MukkadasDepartment of Medical Microbiology Aminu Kano Teaching Hospital, Kano, Nigeria.
D MaduekweWuse General Hospital Abuja, Abuja, Nigeria.
S GamboDepartment of Paediatrics, Murtala Muhammed Specialist Hospital, Kano, Nigeria.
J SaniDepartment of Paediatrics Abdullahi Wase Teaching Hospital, Kano, Nigeria.
T R WalshDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
O B SpillerDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK.ORCID 0000-0002-9117-6911

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) OPP1119772
6 · The paper itself

Abstract

A mobile colistin resistance gene mcr was first reported in 2016 in China and has since been found with increasing prevalence across South-East Asia. Here we survey the presence of mcr genes in 4907 rectal swabs from mothers and neonates from three hospital sites across Nigeria; a country with limited availability or history of colistin use clinically. Forty mother and seven neonatal swabs carried mcr genes in a range of bacterial species: 46 Enterobacter spp. and single isolates of; Shigella, E. coli and Klebsiella quasipneumoniae. Ninety percent of the genes were mcr-10 (n = 45) we also found mcr-1 (n = 3) and mcr-9 (n = 1). While the prevalence during this collection (2015-2016) was low, the widespread diversity of mcr-gene type and range of bacterial species in this sentinel population sampling is concerning. It suggests that agricultural colistin use was likely encouraging sustainment of mcr-positive isolates in the community and implementation of medical colistin use will rapidly select and expand resistant isolates.

Indexed as

ColistinEscherichia coli ProteinsAnti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliFemaleHumansInfant, NewbornMicrobial Sensitivity TestsNigeriaPlasmidsPregnancyPregnant PeopleAnti-Bacterial AgentsColistinEscherichia coli Proteins

Identifiers

PMID38485761
PMCPMC10940312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.